Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:S130-S137
doi: 10.1161/CIRCULATIONAHA.107.757617
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farahmand, P.
Right arrow Articles by Li, R.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farahmand, P.
Right arrow Articles by Li, R.-K.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
*Heart Surgery
Related Collections
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Acute myocardial infarction

(Circulation. 2008;118:S130-S137.)
© 2008 American Heart Association, Inc.


Cell Transplantation and Tissue Regeneration

Skeletal Myoblasts Preserve Remote Matrix Architecture and Global Function When Implanted Early or Late After Coronary Ligation Into Infarcted or Remote Myocardium

Patrick Farahmand, MD; Teresa Y.Y. Lai, MSc; Richard D. Weisel, MD; Shafie Fazel, MD, PhD; Terrence Yau, MD; Philippe Menasche, MD; Ren-Ke Li, MD, PhD

From the Division of Cardiovascular Surgery (P.F., T.Y.Y.L., R.D.W., S.F., T.Y., R.-K.L.), Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada; and the Department of Cardiovascular Surgery (P.F., P.M.), Hopital European Georges Pompidou, Paris, France.

Correspondence to Ren-Ke Li, MD, PhD, MaRS Centre, Toronto Medical Discovery Tower, Room #3-702, 101 College Street, Toronto, Ontario, Canada, M5G 1L7. E-mail renkeli{at}uhnres.utoronto.ca

Background— The inability of skeletal myoblasts to transdifferentiate into cardiomyocytes suggests that their beneficial effects on cardiac function after a myocardial infarction are mediated by paracrine effects. We evaluated the roles of these factors in the preservation of matrix architecture (in the infarct and remote regions) by varying the timing (postmyocardial infarction) and delivery site of the implanted cells.

Methods and Results— Skeletal myoblasts (5x106) or control media were injected into the infarct or noninfarcted myocardium at 5 or 30 days after coronary artery ligation in rats. Function was assessed by echocardiography before transplantation and 14 and 30 days thereafter and with a Millar catheter at 30 days after transplantation. Ventricular geometry, remote fibrillar collagen architecture, and changes in the matrix metalloproteinase-TIMP system were evaluated. Myoblast implantation in both sites and at both times preserved matrix architecture (length and width of collagen fibers) in the remote myocardium (in association with some decreases in remote myocardial matrix metalloprotease activity), improved global cardiac function, and attenuated the progressive increase in end diastolic volume (P<0.05 for all measures compared with medium controls). Cells delivered into the infarct region preserved scar thickness; cells delivered into the noninfarcted myocardium preserved wall thickness.

Conclusions— Regardless of whether the cells were injected into the infarct or the noninfarcted myocardium early after an myocardial infarction or later, skeletal myoblasts improved cardiac function by preventing ventricular dilation and preserving matrix architecture in the remote region, likely mediated by paracrine effects.


Key Words: cells • heart failure • myocardial infarction • remodeling • transplantation